We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
ArisGlobal, a provider of life sciences software that automates core drug development with its end-to-end drug development technology platform LifeSphere®, announced the go-live of the FDA Adverse Event Reporting System (FAERS II), an electronic safety...
ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end drug development technology platform LifeSphere® today announced its partnership...
ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, today announced one of the world's largest tobacco manufacturing companies has selected LifeSphere® MultiVigila